PE20020253A1 - Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos - Google Patents

Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos

Info

Publication number
PE20020253A1
PE20020253A1 PE2001000604A PE2001000604A PE20020253A1 PE 20020253 A1 PE20020253 A1 PE 20020253A1 PE 2001000604 A PE2001000604 A PE 2001000604A PE 2001000604 A PE2001000604 A PE 2001000604A PE 20020253 A1 PE20020253 A1 PE 20020253A1
Authority
PE
Peru
Prior art keywords
alkyl
ethyl
hexane
derivatives
halo
Prior art date
Application number
PE2001000604A
Other languages
English (en)
Spanish (es)
Inventor
Bernard Joseph Banks
Douglas James Critcher
Stephen Paul Gibson
David Morris Gethin
Ashley Edward Fenwick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE20020253A1 publication Critical patent/PE20020253A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
PE2001000604A 2000-06-23 2001-06-21 Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos PE20020253A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015562.2A GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles

Publications (1)

Publication Number Publication Date
PE20020253A1 true PE20020253A1 (es) 2002-04-08

Family

ID=9894368

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000604A PE20020253A1 (es) 2000-06-23 2001-06-21 Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos

Country Status (34)

Country Link
EP (1) EP1292574A1 (hu)
JP (1) JP2004512263A (hu)
KR (1) KR20040002386A (hu)
CN (1) CN1639121A (hu)
AP (1) AP2002002698A0 (hu)
AR (1) AR028969A1 (hu)
AU (1) AU781837B2 (hu)
BG (1) BG107329A (hu)
BR (1) BR0111867A (hu)
CA (1) CA2412188A1 (hu)
CZ (1) CZ20023967A3 (hu)
DO (1) DOP2001000187A (hu)
DZ (1) DZ3368A1 (hu)
EA (1) EA005117B1 (hu)
GB (1) GB0015562D0 (hu)
HR (1) HRP20020998A2 (hu)
HU (1) HUP0301228A3 (hu)
IL (1) IL153427A0 (hu)
IS (1) IS6637A (hu)
MA (1) MA26915A1 (hu)
MX (1) MXPA02012878A (hu)
NO (1) NO20026168L (hu)
NZ (1) NZ523141A (hu)
OA (1) OA12293A (hu)
PA (1) PA8519401A1 (hu)
PE (1) PE20020253A1 (hu)
PL (1) PL365956A1 (hu)
SK (1) SK17172002A3 (hu)
TN (1) TNSN01094A1 (hu)
UA (1) UA73176C2 (hu)
UY (1) UY26787A1 (hu)
WO (1) WO2001098267A1 (hu)
YU (1) YU91802A (hu)
ZA (1) ZA200210278B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1440059T1 (sl) * 2001-10-22 2008-08-31 Pfizer Prod Inc Derivati 3-azabiciklo(3.1.0)heksana kot antagonisti opioidnega receptorja
AU2003242527B2 (en) * 2002-05-17 2008-10-23 Tioga Pharmaceuticals, Inc. Use of compounds that are effective as selective opiate receptor modulators
DE10259245A1 (de) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
TW200538113A (en) 2004-02-23 2005-12-01 Glaxo Group Ltd Compounds
GB0507680D0 (en) 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE484502T1 (de) * 2005-06-14 2010-10-15 Glaxo Group Ltd Neue verbindungen
US8163927B2 (en) 2006-04-03 2012-04-24 Glaxo Group Limited Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
EP2136801B1 (en) 2007-03-30 2012-08-29 Tioga Pharmaceuticals, Inc. Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
WO2012042539A2 (en) 2010-09-28 2012-04-05 Panacea Biotec Ltd Novel bicyclic compounds
MX2016006482A (es) 2013-11-20 2016-12-09 Sanwa Kagaku Kenkyusho Co Derivado novedoso de 3-azabiciclo[3.1.0]hexano y uso del mismo para proposito medico.
CA2985327A1 (en) 2015-05-20 2016-11-24 Sanwa Kagaku Kenkyusho Co., Ltd. Crystal of salt of 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof
JP7185633B2 (ja) 2017-02-17 2022-12-07 トレベナ・インコーポレイテッド 7員アザ複素環を含有するデルタ-オピオイド受容体調節化合物、その使用方法及び製造方法
EP3582779B1 (en) * 2017-02-17 2024-04-17 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
WO2018159716A1 (ja) 2017-03-02 2018-09-07 株式会社 三和化学研究所 アルコール使用障害の治療薬
CN108250088B (zh) * 2018-01-04 2020-10-30 四川之江高新材料股份有限公司 N,n,n′-三甲基-n′-羟乙基双氨基乙基醚的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065230A (en) * 1959-03-16 1962-11-20 Burroughs Wellcome Co Azabicyclohexanes and method of preparing them
EP0287339B1 (en) * 1987-04-16 1994-08-17 Eli Lilly And Company Piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
PE20001420A1 (es) * 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy

Also Published As

Publication number Publication date
UY26787A1 (es) 2002-01-31
CN1639121A (zh) 2005-07-13
NZ523141A (en) 2005-06-24
WO2001098267A1 (en) 2001-12-27
DOP2001000187A (es) 2002-03-30
PL365956A1 (en) 2005-01-24
JP2004512263A (ja) 2004-04-22
WO2001098267A8 (en) 2003-02-27
AP2002002698A0 (en) 2002-12-31
CZ20023967A3 (cs) 2004-02-18
SK17172002A3 (sk) 2004-09-08
NO20026168D0 (no) 2002-12-20
IL153427A0 (en) 2003-07-06
PA8519401A1 (es) 2002-12-30
HUP0301228A2 (hu) 2003-08-28
EA005117B1 (ru) 2004-10-28
AU781837B2 (en) 2005-06-16
KR20040002386A (ko) 2004-01-07
BG107329A (en) 2003-07-31
MXPA02012878A (es) 2003-05-14
EA200201269A1 (ru) 2003-06-26
AR028969A1 (es) 2003-05-28
UA73176C2 (en) 2005-06-15
YU91802A (sh) 2006-05-25
MA26915A1 (fr) 2004-12-20
OA12293A (en) 2004-03-18
HUP0301228A3 (en) 2005-08-29
NO20026168L (no) 2003-02-18
ZA200210278B (en) 2003-12-19
TNSN01094A1 (fr) 2005-11-10
GB0015562D0 (en) 2000-08-16
HRP20020998A2 (en) 2004-02-29
CA2412188A1 (en) 2001-12-27
EP1292574A1 (en) 2003-03-19
IS6637A (is) 2002-11-28
BR0111867A (pt) 2003-07-01
DZ3368A1 (fr) 2001-12-27
AU6259101A (en) 2002-01-02

Similar Documents

Publication Publication Date Title
PE20020253A1 (es) Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos
PE20010964A1 (es) Derivados de tiazolilamida
PE20061297A1 (es) Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c
DK1173433T3 (da) Cyanopyrroler som progesteronreceptoragonister
PE20030039A1 (es) Derivados de indol con afinidad por el receptor 5-ht6
PE20020354A1 (es) Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
PE20050482A1 (es) Derivados de dihidrobenzofuranilo alcanamida
PE20070189A1 (es) COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA
ATE317378T1 (de) Triphenylalkenderivate und ihre anwendung als selektive modulatoren des östrogenrezeptors
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
PE20090276A1 (es) Compuestos derivados de imidazoquinolina como moduladores de tlr7
PE20001643A1 (es) Uso de antagonistas de crf que mejora la dispersion de qt y la variabilidad de la frecuencia cardiaca para prevenir muerte subita
PE20020131A1 (es) Derivados de pirazol
AR036906A1 (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4
PE20011212A1 (es) Compuestos para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
PE20050420A1 (es) Fenacilo 2-hidroxi-3-diaminoalcanos
NO952208D0 (no) Amin-derivater
AR038881A1 (es) Compuestos que modulan la actividad de ppar, composicion farmaceutica que los contiene y un procedimiento para la preparcion de aquellos
PE20020063A1 (es) Bis-arilsulfonas como ligandos del receptor de 5-ht
DK1153017T3 (da) Bicykliske forbindelser og deres anvendelse som integrinreceptorligander
AR039111A1 (es) Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas
AR015964A1 (es) Compuestos de isoquinolina, su uso, procedimiento para tratar una afeccion, procedimiento de preparacion del compuesto, composicion farmaceutica que locontiene y compuesto util en dicho procedimiento
GEP20084544B (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
RU2009101299A (ru) Трициклическое соединение и его фармацевтическое применение
PE20020436A1 (es) Derivados de tetrahidropirano como antagonistas del receptor de neuroquinina 1 (nk-1)

Legal Events

Date Code Title Description
FC Refusal